Iran Develops Device that Accurately Locates Tumors
WANA (Mar 16) – An Iranian knowledge-based company has successfully developed a neuro-navigation system for brain surgery at one-fourth the cost of its foreign counterparts. This advanced device aids surgeons in precisely locating tumors, particularly in complex cases where access is challenging, reducing the risk of damage to surrounding healthy tissues and improving surgical outcomes.
According to CEO Alireza Ahmadian, the system matches the accuracy of leading international brands like Brainlab and Medtronic while offering a more user-friendly interface. It integrates multiple imaging technologies, including CT, MRI, fMRI, and DTI, enhancing precision during surgery.
Explaining its functionality, Ahmadian noted that the system aids surgeons in accurately identifying the tumor site during surgeries where access is difficult.
This minimizes damage to surrounding healthy tissues, enhances surgical precision, and reduces postoperative complications. Additionally, the system improves the likelihood of complete tumor removal, significantly lowering the risk of recurrence and the need for repeat surgeries.
He added that the device is highly beneficial for neurosurgery, ENT, orthopedics, and spinal procedures. To date, it has been deployed in over 95 specialized hospitals across Iran, assisting more than 190 top surgeons in thousands of surgeries.
Its affordability has saved the country approximately €25 million in foreign exchange. The company produces 12 units annually and has successfully exported to Ecuador, Russia, and Germany.
Ahmadian concluded by noting that the project has directly created 30 jobs and indirectly provided employment for 150 individuals.